SANXING(SH:601567) Xin Lang Cai Jing·2025-12-31 01:46Group 1 - The core viewpoint of the news is that Samsung Medical's stock has experienced a decline, with a current price of 22.69 yuan per share and a market capitalization of 31.884 billion yuan [1] - Samsung Medical, established on February 1, 2007, and listed on June 15, 2011, is primarily engaged in the research, production, and sales of electric energy metering and information collection products, as well as distribution equipment and medical services [1] - The revenue composition of Samsung Medical shows that the electric power segment accounts for 79.70% of total revenue, medical services contribute 19.15%, and other business revenues make up 1.15% [1] Group 2 - From the perspective of fund holdings, one fund under Southern Fund has a significant position in Samsung Medical, specifically the Southern New Energy Industry Trend Mixed A fund, which holds 1.8714 million shares, unchanged from the previous period, representing 5.41% of the fund's net value [2] - The Southern New Energy Industry Trend Mixed A fund has a total scale of 733 million yuan and has achieved a year-to-date return of 22.99%, ranking 4024 out of 8085 in its category [2] - The fund manager, Xiong Lin, has been in position for 4 years and 130 days, with the best and worst fund returns during this period being -22.72% and -24.71%, respectively [3]